News & Analysis on Clinical Trial Services & Contract Research And Development
An innovative new platform technology with a myriad of applications has been developed by a UK firm, and promises to be a novel arrow in the quiver of the pharma industry in its attempts to shoot down drug counterfeiters.
ActivX has launched a new profiling platform, which the company claims allows the functional analysis of twice the number of protein kinases than competing systems.
GlaxoSmithKline (GSK) has today opened a new medicinal chemistry laboratory in Singapore and plans to double the number of researchers hired at the site to 60.
The purchase of Canada's Allied Research International (ARI) has given Cetero Research a boost to its early-phase clinical services and geographic reach in Canada.
A novel method of delivering a hydrophobic (water-insoluble) drug, in which the compound effectively acts as its own carrier, has shown comparable efficacy both in vitro and in vivo to the same drug formulated in a conventional delivery vehicle.
The European Parliament has backed proposed legislation to impose hefty fines and penalties on criminals taking part in piracy and counterfeiting activities.
Merck has bestowed leading Chinese R&D services firm WuXi PharmaTech with an outsourcing-provider award.
PharmaNet has been told by the US Securities and Exchange Commission (SEC) that it will now be the subject of a formal investigation as it continues to be haunted by the early phase unit it used to own in Miami.
Sanofi-Aventis is gearing up for the European roll-out of a new disposable insulin pen designed to address a broader spectrum of patient needs than currently available injection devices.
Researchers have created a new strain of wheat with an inbuilt resistance to devastating scab blight which infects wheat heads - reducing crop yields as well as market value and quality.